uring the 1980s, indications for the existence of intramembrane interactions between different G protein-coupled receptors, mainly between neuropeptide and monoamine receptors, were obtained in several brain areas (1, 2). It was later proposed that a possible molecular mechanism for this phenomenon was receptor heteromerization (3) and direct evidence for homo-and heteromerization of G protein-coupled receptors has been obtained by several groups. It was first shown that serotonin 5-HT-1B receptors exist as monomers and dimers (4). This was followed by demonstration of dimers and oligomers of dopamine D 1 and D 2 receptors (D 1 and D 2 R) in transfected Sf cells (5-7) and of adenosine A 1 receptors (A 1 Rs) in a natural cell line and in mammalian brain (8). It has recently been reported that a fully functional ␥-aminobutyric acid (GABA) type B receptor demands the heterodimerization of GABA B R1 and GABA B R2 receptors (9-12). Moreover, two functional opioid receptors, the and ␦ subtypes, can undergo heteromerization, which changes the pharmacology of the individual receptors and potentiates signal transduction (13). Finally, D 2 R and somatostatin receptor subtype 5 have been shown to physically interact by forming heterooligomers with enhanced functional activity (14). Direct protein-protein coupling can also exist between G proteincoupled anion channel receptors, as recently shown for dopamine D5 receptor and GABA A receptor, making possible bilateral inhibitory interactions between these receptors (15).
D
uring the 1980s, indications for the existence of intramembrane interactions between different G protein-coupled receptors, mainly between neuropeptide and monoamine receptors, were obtained in several brain areas (1, 2) . It was later proposed that a possible molecular mechanism for this phenomenon was receptor heteromerization (3) and direct evidence for homo-and heteromerization of G protein-coupled receptors has been obtained by several groups. It was first shown that serotonin 5-HT-1B receptors exist as monomers and dimers (4). This was followed by demonstration of dimers and oligomers of dopamine D 1 and D 2 receptors (D 1 and D 2 R) in transfected Sf cells (5) (6) (7) and of adenosine A 1 receptors (A 1 Rs) in a natural cell line and in mammalian brain (8) . It has recently been reported that a fully functional ␥-aminobutyric acid (GABA) type B receptor demands the heterodimerization of GABA B R1 and GABA B R2 receptors (9) (10) (11) (12) . Moreover, two functional opioid receptors, the and ␦ subtypes, can undergo heteromerization, which changes the pharmacology of the individual receptors and potentiates signal transduction (13) . Finally, D 2 R and somatostatin receptor subtype 5 have been shown to physically interact by forming heterooligomers with enhanced functional activity (14) . Direct protein-protein coupling can also exist between G proteincoupled anion channel receptors, as recently shown for dopamine D5 receptor and GABA A receptor, making possible bilateral inhibitory interactions between these receptors (15) .
Antagonistic adenosine͞dopamine interactions have been widely reported in the central nervous system in behavioral and biochemical studies. Furthermore, in animal models, adenosine agonists and antagonists are potent atypical neuroleptics and antiparkinsonian drugs, respectively (16) (17) (18) . Thus, adenosine agonists inhibit and adenosine antagonists, such as caffeine, potentiate the behavioral effects induced by dopamine agonists. The evidence suggests that this antagonism is at least in part caused by an intramembrane interaction between specific subtypes of dopamine and adenosine receptors, namely, between A 1 Rs and D 1 Rs and between adenosine A 2A receptors (A 2A Rs) and D 2 Rs (16). This antagonism is evident in crude membrane preparations from cell lines expressing the two receptors and from rat striatum in which, for instance, activation of A 1 Rs reduces the proportion of D 1 Rs in the high-affinity state without changing the dissociation constants of the high-and the lowaffinity binding sites (19, 20) . In the present paper, indications have been obtained that the postulated intramembrane interactions between A 1 Rs and D 1 Rs may involve the formation of heteromeric complexes regulated by A 1 R and D 1 R agonists. (20) . For control experiments, Ltk Ϫ cells cotransfected with human D 2 R (long-form) and human A 1 R cDNAs (A 1 ͞D 2 cells) were obtained with the calcium phosphate precipitation method (20) . Ltk Ϫ cells were grown as described (20) . Primary cultures of neurons were obtained from 17-to 18-day-old SpragueDawley rat embryos as described (21) .
Methods
Radioligand-Binding Experiments. Membrane preparations from Ltk Ϫ cells were obtained as described (20 Abbreviations: A1R, adenosine A1 receptor; D1R, dopamine D1 receptor; D2R, dopamine D2 receptor; R-PIA, (R)-(Ϫ)N 6 -(2-phenylisopropyl)adenosine. † † To whom reprint requests should be addressed. E-mail: r.franco@sun.bq.ub.es.
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Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073͞pnas.150241097. Article and publication date are at www.pnas.org͞cgi͞doi͞10.1073͞pnas.150241097 as described (20, 22) . Data from saturation experiments were analyzed by nonlinear regression analysis (GRAPHPAD) for the determination of dissociation constants (K d ) and the total number of receptors (B max ). Data from competition experiments were also analyzed by nonlinear regression analysis, and the dissociation constants for the high-affinity (K H ) and low-affinity (K L ) binding sites and the proportion of binding sites in the high-affinity state (R H ) were determined. The amount of nonspecific binding was calculated by extrapolation of the displacement curve. Protein determinations were performed by using BSA as a standard. The Mann-Whitney U test was used to analyze differences in R H , K H , and K L values. (25) for 1 h at 37°C. The coverslips were rinsed for 40 min in the same buffer and mounted with medium for immunofluorescence (ICN). Confocal microscopic observations were made with a Leica TCS 4D (Leica Lasertechnik, Heidelberg, Germany) confocal scanning laser equipment adapted to an inverted Leitz DMIRBE microscope. The extent of colocalization of the two labelings was assessed by means of computerized image analysis (KS300, Kontron, Zurich). A couple of images of the same field stained with the two labelings were analyzed at each time. In each image, the specific staining was discriminated from the nonspecific background by means of the threshold function and the discriminated images of the two labelings were superimposed and subtracted by means of the AND Boolean operator function. By using this function, a new image is created containing only pixels that are positive in both original discriminated images. The percent coexistence is obtained by expressing the number of positive pixels in the new image in percent of the number of positive pixels in each of the original discriminated images.
Immunoprecipitation of A1R, D1R, and D2R. A 1 ͞D 1 cotransfected cells were incubated in the absence or presence of 100 nM R-PIA or 10 M SKF-38393 in serum-free medium for 1 h at 37°C. Cell membranes were obtained by centrifugation (105,000 ϫ g for 45 min at 4°C) after disruption of cells with a Polytron homogenizer (Kinematica, PTA 20TS rotor, setting 4; Brinkmann) for three 5-s periods in 50 mM Tris⅐HCl, pH 7.4. Membranes were separated at 105,000 ϫ g (45 min at 4°C). Pretreated or control membranes were solubilized in ice-cold lysis buffer (PBS, pH 7.4͞1% Nonidet P-40͞0.5% sodium deoxycholate͞0.1% SDS) for 1 h on ice and then centrifuged at 80,000 ϫ g for 90 min. The supernatants (1 mg of protein per ml) were precleared by incubation (6 h) with staphylococcal protein A-Sepharose beads. After centrifugation at 10,000 ϫ g for 15 s, the supernatants were transferred to a tube containing affinity-purified anti-A 1 R antibody (PC11) (8) or a control rabbit IgG, both antibodies covalently coupled to protein A-Sepharose (24) . Nonspecific immunoprecipitation was performed by incubating the same amount of protein A-Sepharose coupled to anti-A 1 R antibody with membrane extracts (obtained as described above) from D 1 cells, which do not express A 1 R. Immunoprecipitates were washed twice in ice-cold lysis buffer containing 0.1% Nonidet P-40͞0.05% sodium deoxycholate͞0.01% SDS and once in icecold PBS, pH 7.4. After centrifugation and isolation of the beads, 60 l of SDS͞PAGE sample buffer was added to the beads. Immune complexes treated at 37°C for 15 min were resolved by SDS͞PAGE in 12.5% gels. Proteins were transferred to poly-(vinylidene difluoride) (PVDF) membranes (Immobilon-P, Millipore) for 1 h by using a wet transfer system in Towbin buffer (25 mM Tris͞192 mM glycine͞20% methanol, pH 8.3). Nonspecific protein binding sites on the PVDF membranes were blocked by incubation overnight at 4°C by using 10% (wt͞vol) dehydrated milk in PBS. After blocking, PVDF membranes were washed three times (10 min per wash) in 10 mM Tris⅐HCl buffer containing 500 mM NaCl and 0.5% Tween-20 (TBS-TII; pH 7.4) and incubated for 2 h with the purified anti-A 1 R antibody (PC11; 10 g͞ml), purified anti-D 1 R antibody (D 1 -356-446; 10 g͞ml), or purified anti-D 2 R antibody (D 2 -246-316; 10 g͞ml) in TBS-TII, including 0.02% NaN 3 . Immunoreactive bands were detected with a donkey anti-rabbit IgG antibody conjugated to horseradish peroxidase (1͞10,000 Promega W401 B 8846301), followed by development with a chemiluminescence detection system (Pierce SuperSignal). A similar protocol was used to study possible coimmunoprecipitation of A 1 R and D 2 R, by using an anti-D 2 R antibody (25) for immunoprecipitation and immunoblotting in membranes from A 1 ͞D 2 cells. (Fig. 2A) . When the cells were treated for 1 h with the A 1 R agonist R-PIA, a redistribution of A 1 Rs and D 1 Rs was observed (Fig. 2B) . Thus, R-PIA induced the aggregation of both proteins in clusters seen as punctate fluorescence, where colocalizations between adenosine and dopamine receptors approach 100% (see the intensity of yellow in Fig. 2B ). In contrast, the D 1 R agonist SKF-38393 clustered D 1 Rs but not A 1 Rs (Fig. 2C) . The R-PIA-or SKF-38393-induced clusters had a similar appearance; the clusters were very variable in size with no preferential localization within the cell. Furthermore, combined treatment with SKF-38393 and R-PIA as above did not result in any clustering either of the D 1 R or the A 1 R (Fig.  2D) .
cAMP determination. In A 1 ͞D 1 fibroblast cells, pretreatment with the D 1 R agonist SKF-38393 (10 M) for 30-120 min did not alter the SKF-38393-induced increase in cAMP accumulation (Fig. 3) . The same was also true after pretreatment with 100 nM of R-PIA for 30-120 min. In contrast, a significant reduction of the SKF-38393-induced cAMP accumulation was found after combined pretreatment with SKF-38393 (10 M) and R-PIA (100 nM) for 60 and 120 min (Fig. 3) . Immunoprecipitation experiments. As seen in Fig. 1 (Fig. 4A) or presence (Fig. 4B) of R-PIA.
Studies on Primary Rat Cortical Cultures. As seen in Fig. 5 , the cultured neurons showed A 1 R and D 1 R immunoreactivity. The location of both receptors was diffuse in the soma and dendrites with a high degree of colocalization (Fig. 5A) . The degree of colocalization between A 1 R and D 1 R immunoreactivity was similar to that found in cotransfected fibroblast cells. The A 1 R agonist R-PIA reproduced the clustering effect on D 1 Rs and A 1 Rs observed in the cotransfected fibroblast cells (Fig. 5B) . In these cultures, also SKF-38393 (10 M, 1 h) produced clustering with a high degree of colocalization of D 1 Rs and A 1 Rs (Fig. 5C) . The simultaneous treatment with SKF-38393 (10 M) and R-PIA (100 nM) for 1 h instead blocked the formation of the A 1 R͞D 1 R clusters seen with either of the agonists alone (Fig. 5D ).
Discussion
The existence of homo-and͞or heteromers of G protein-coupled receptors has recently been proposed and experimental evidence for this concept is starting to be obtained (see Introduction). In the present paper, it is shown that D 1 Rs and A 1 Rs form heteromeric complexes under basal conditions and that they can coaggregate (cocluster) under some specific agonist-stimulated conditions. The two phenomena appear to be related to each Notably, after A 1 R͞D 1 R coactivation, the two receptors remain physically associated, but differently from the effect of A 1 R activation alone, do not form clusters. These data show that A 1 R activation influences the D 1 Rs, which are and remain physically associated in a heteromeric complex, and leads to an uncoupling of D 1 R from adenylyl cyclase only when the D 1 Rs are simultaneously activated. Thus, the temporal dynamics of receptor activation and heteromerization may play a key role in A 1 R͞D 1 R interactions. The uncoupling of D 1 R and Gs occurring in coactivated A 1 R͞D 1 R heteromers may contribute to adenosine inhibition of D 1 R function, and complement the known A 1 Rinduced inhibition of D 1 R function mediated by the activation of Gi (19, 20) . Overall, A 1 R-and D 1 R-mediated transmission, heteromerization, and clustering are phenomena related to each other in a complex manner. Homogeneous or heterogeneous clustering does not appear to be a necessary consequence of receptor activation but it may be a prerequisite for internalization (26) . On the other hand, the mono-, homo-, or heteromeric state of A 1 R and D 1 R is not related in an obvious way to receptor clustering. In fact, the role of homo-and heteromerization may be different in different systems (9) (10) (11) (12) 27) .
The colocalization of D 1 Rs and A 1 Rs as well as their clustering in response to A 1 and͞or D 1 agonist treatment as described above was also analyzed in primary cultures of neurons from rat cerebral cortex. A 1 Rs and D 1 Rs were highly colocalized and diffusely distributed to the soma and dendrites of the cortical neurons, which is consistent with previous studies that identified D 1 Rs and A 1 Rs in cell bodies, dendrites, and spines mainly at extrasynaptic locations (28, 29) . The A 1 R agonist R-PIA reproduced in neurons the effects already observed in cotransfected fibroblast cells, i.e., increases in A 1 R͞D 1 R colocalization up to 100% and coaggregation in clusters. In contrast to the A 1 R͞ D 1 R-cotransfected fibroblast cells, the effect of SKF-38393 in neurons was similar to that of R-PIA, namely a coclustering of D 1 Rs and A 1 Rs. These differential actions may reflect differences in the relative amount of the receptors in the A 1 R͞D 1 R complexes in the neurons as compared with cotransfected fibroblasts. In addition, the neurons may have membrane components that the A 1 R͞D 1 R-cotransfected cells do not express, leading to the coclustering of A 1 R͞D 1 R also after the D 1 R agonist pretreatment. Nevertheless, the simultaneous pretreatment of neurons with the D 1 R and the A 1 R agonists reproduced the results obtained in A 1 R͞D 1 R-cotransfected cells with failure to cluster either one of the receptors.
Based on immunoprecipitation and double immunolabeling experiments, evidence is presented for the existence of A 1 R and D 1 R heteromers, and their presence in membranes of cotransfected fibroblast cells. Functional experiments on the D 1 R agonist-induced cAMP production suggest that coactivation of A 1 R and D 1 R in the heteromeric complex leads to an uncoupling of D 1 R from Gi. This antagonistic mechanism may contribute to the A 1 R͞D 1 R functional antagonism found in the brain and offers a basis for the design of novel agents to treat Parkinson's disease and neuropsychiatric disorders, based on the pharmacological properties of the A 1 ͞D 1 heteromeric complex.
